Lovastatin: Immunomodulatory Value Evaluation

NCT00721305 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

OTHER

Sponsor class

Conditions

HIV Seropositivity

Interventions

DRUG: Lovastatin
OTHER: placebo

Sponsor

Universidad de Antioquia

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]